InhalopédiaLa brigade d'AlliPodcastsActualitésMentions légales
Coeur Poumons Coeur Poumons
 /  Maladies  / Maladies métaboliques  / Obésité  /  Références

Obésité

Partager cette page
Obésité

Références

Partager cette page
En savoir plus

Références utilisées pour le contenu de cette section

  1. Altfas JR. Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment. BMC Psychiatry. 2002 Sep; 2:9.
  2. American Psychiatric Association. DSM-5 : Manuel diagnostique et statistique des troubles mentaux. 5e ed. Issy-les-Moulineaux: Elsevier Masson SAS; 2015.
  3. Berthoud HR, Lenard NR. Food reward, hyperphagia, and obesity. AJP Regulatory Integrative and Comparative Physiology. 2011 Jun; 300(6): 1266-77
  4. Beydoun MA, Beydoun HA, Wang Y. Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev. 2008 May; 9(3): 204-218
  5. Bhaskaran K, Dos-Santos-Silva I, Leon DA et coll. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol. 2018 Dec; 6(12): 944–53.
  6. Bouter KE, Van Raalte DH, Groen AK et coll. Role of the gut microbiome in the pathogenesis of obesity and obesity-related metabolic dysfunction. Gastroenterology. 2017 May; 152(7): 1671-1678.
  7. Brooks SJ, Cedarnaes J. Increased prefrontal and parrahippocampal with reduced prefrontal and insular cortex activation to food image in obesity: a meta-analysis of fMRI studies. PlosOne. 2013 Apr; 8(4): e60393
  8. Brown J, Clarke C, Johnson Stoklossa C, Sievenpiper J. Canadian Adult Obesity Clinical Practice Guidelines: Medical Nutrition Therapy in Obesity Management. Site internet: https://obesitycanada.ca/guidelines/nutrition
  9. Calle EE, Rodriguez C, Walker-Thurmond K et coll. Overweight, Obesity, and Mortality From Cancer in a Prospectively Studied Cohort of U.S. N Engl J Med. 2003 Apr 24; 348(17): 1625-38.
  10. Chirurgie bariatrique, Obésité Canada. https://obesitycanada.ca/fr/gestion-de-lobesite/chirurgies-bariatriques/
  11. Chirurgie bariatrique : Sélection et bilan préopératoire. (2020) https://obesitycanada.ca/fr/deslignesdirectrices/selection/
  12. CMAJ 2020 August 4;192:E875-91. doi: 10.1503/cmaj.191707
  13. Crewe C, An YA, Scherer PE. The ominous triad of adipose tissue dysfunction:Inflammation, fibrosis, and impaired angiogenesis. J Clin Invest. 2017 Jan; 127(1): 74-82
  14. Dickerson FB, Brown CH, Kreyenbuhl JA, et al. Obesity among individuals with serious mental illness. Acta Psychiatr Scand. 2006 Apr; 113(4): 306-313.
  15. Dingemans, A.E., Bruna, M.J., & van Furth, E.F. Binge eating disorder: a review. International Journal of Obesity. 2020 Mar; 26(3): 299-307.
  16. Dye L, Boyle NB, Champ C, Lawton C. The relationship between obesity and cognitive health and decline. Proc Nutr Soc. 2017 Nov; 76(4): 443-454
  17. Engin A, Circadian rhythms in Diet-Induced Obesity, Adv Exp Med Biol, 2017;960:19-52. doi: 10.1007/978-3-319-48382-5_2.
  18. Enquête canadienne sur les mesures de la santé : données sur les ménages et les mesures physiques, 2016 et 2017.
  19. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord. 2005 Oct; 7(5): 424-430.
  20. Fagiolini A, Kupfer DJ, Houck PR, Novick DM, Frank E. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry. 2003 Jan; 160(1): 112-117.
  21. Fothergill E, Guo J, Howard L et coll. Persistent metabolic adaptations 6 years after the Biggest Losers competition, Obesity. 2016 Aug; 24(8): 1612-19.
  22. Gallagher EJ, LeRoith D. Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality. Physiol Rev. 2015 Jul; 95(3): 727–748.
  23. Gilbert R, Widom CS, Browne K, Fergusson D, Webb E, Janson S. Burden and consequences of child maltreatment in high-income countries. Lancet. 2009 Jan; 373(9657): 68-81.
  24. Goldberg, JF, Ernst, CL, 2018, Managing the side effects of psychotropic medications, 2ème ed., American Psychatric Association, Washington, DC.
  25. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med. 2003 Jul; 163(13): 1524-1528
  26. Hollander P. Anti-Diabetes and Anti-Obesity Medications: Effects on Weight in People With Diabetes. Diabetes Spectrum. 2007 Jul; 20(3): 159-65.
  27. Holst JJ, Madsbad S, Bojsen-Moller KN. Mechanism in bariatric surgery: Gut hormones, diabetes resolution and weight loss. Surgery for Obesity and Related Diseases. 2018 May; 14(5): 708-714.
  28. Hudson, J.I., Hiripi, E., Pope, H.G., & Kessler, R.C. The Prevalence and Correlates of Eating Disorders in the National Comorbidity Survey Replication. Biological Psychiatry. 2007 Feb; 61(3): 348-58. [Erratum dans Biological Psychiatry. 2012; 72(2): 164.
  29. Igel LI, Kummar RB, Saunders KH et coll. Practical Use of Pharmacotherapy for Obesity. Gastroenterology. 2017 May; 152(7): 1765-1779.
  30. Institut de la statistique du Québec., 2018-2019. Enquête québécoise sur l’activité physique et le sport. Québec
  31. Janssen, I. et coll. Influence of Individual- and Area-level Measures of Socioeconomic Status on Obesity, Unhealthy Eating, and Physical Inactivity in Canadian Adolescents, American Journal of Clinical Nutrition, vol. 83 (2006) : pp. 139-145.
  32. Jensen MD, Ryan D, Apovian C et all, AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults, Circulation ,published online November 12, 2013
  33. Lavallée Mélanie, Application Bariatrique Québec, chapitre Santé mentale et obésité, 2021
  34. L’obésité chez les adultes canadiens, 2016 et 2017. https://www150.statcan.gc.ca/n1/fr/pub/11-627-m/11-627-m2018033-fra.pdf?st=6yFBFa4F
  35. M DEH, Correll CU, Bobes J, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011 Feb; 10(1): 52-77
  36. Marso S, Daniels G, Brown-Frandsen K et coll. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016 Jul; 375(4): 311-322.
  37. McElroy SL, Frye MA, Suppes T, et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry. 2002 Mar; 63(3): 207-213.
  38. McElroy SL, Kotwal R, Malhotra S, Nelson EB, Keck PE, Nemeroff CB. Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry. 2004 May; 65(5): 634-651, quiz 730
  39. Mechanick J, Apovian C, Brethauer S. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures – 2019 update. Surg. Obes. Relat. Dis. 2020 Feb; 16(2): 175-247.
  40. Mitchell KS, Aiello AE, Galea S, Uddin M, Wildman D, Koenen KC. PTSD and obesity in the Detroit neighborhood health study. Gen Hosp Psychiatry. 2013 Nov-Dec; 35(6): 671-673
  41. Nissen SE, Wolski KE, Prcela L et coll. Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors A Randomized Clinical Trial. JAMA. 2016 Mar; 315(10): 990-1004.
  42. Obésité. (2019). In A. Youdim, Le Manuel Merck.
  43. Obésité et chirurgie: guide de l’usager (2017). Turgeon, N. IUCPQ
  44. Padwal RS, Pajewski NM, Alisson DB et all, Using de Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ, October 4, 2011; 183(14): 1059-1066
  45. Peppard PE, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284(23): 3015-3021.
  46. Piche ME, Auclair A, Harvey J, Marceau S, Poirier P. How to choose and use bariatric surgery in 2015. Can J Cardiol. 2015 Feb; 31(2): 153-166.
  47. Porter, R. S., & Kaplan, J. L. (2011). Le Manuel Merck. 19th ed. / Whitehouse Station, N.J.: Merck Sharp & Dohme Corp.
  48. Rosengren A, Skoog I, Gustafson D, Wilhelmsen L. Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med. 2005 Feb; 165(3): 321-326.
  49. Rueda-Clausen CF, Poddar M, Lear SA, Poirier P, Sharma AM. Canadian Adult Obesity Clinical Practice Guidelines: Assessment of People Living with Obesity. Site internet : https://obesitycanada.ca/guidelines/assessment.
  50. Sockalingam S et Hawa R. Psychopharmacology in bariatric surgery patients. Psychiatric care in severe obesity. Springer International publishing AG 2017; 1-357.
  51. Spence, J. et coll. Relation Between Local Food Environments and Obesity Among Adults, BMC Public Health, vol. 9, no 192 (2009).
  52. Statistique Canada. Tableau 13-10-0373-01 Embonpoint et obésité selon l’indice de masse corporelle mesuré, selon le groupe d’âge et le sexe 
  53. Stunkard A, Harris J, Pedersen N et coll. The body mass index of twins who have been reared apart. N Engl J Med. 1990 May; 322(21): 1483-1487
  54. Sumithran P, Prendergast LA, Delbridge E et coll. Long term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011 Oct; 365(17): 1597-604.
  55. Taylor VH, McIntyre RS, Remington G, Levitan RD, Stonehocker B, Sharma AM. Beyond pharmacotherapy: understanding the links between obesity and chronic mental illness. Can J Psychiatry. 2012 Jan; 57(1): 5-12.
  56. Theisen FM, Linden A, Geller F, et al. Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication. J Psychiatr Res. 2001 Nov-Dec; 35(6): 339-345.
  57. Verhaegen AA et Gaal LFV. Drugs that affect body weight, body fat distribution and metabolism. Endotext. Mise à jour : 11 février 2019. Bookshelf ID: NBK537590 PMID: 30779535
  58. Vigilance santé. Rx vigilance (Version 1.4.100.1) [logiciel]: Section des antidépresseurs/tableau.
  59. Vincent RP, Ashrafian H. Mechanism of the disease: the role of gastrointestinal hormones in appetite and obesity. Nature Clinical Practice Gastroenterology and Hepatology. 2008 May; 5(5): 268-77
  60. Weiner M, Warren L, Fiedorowicz JG. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry. 2011 Feb; 23(1): 40-47
  61. Wharton, S., Lau, D. C., Vallis, M., Sharma, A. M., Biertho, L., Campbell-Scherer, D., … & Boyling, E. (2020). L’obésité chez l’adulte : ligne directrice de pratique clinique. CMAJ, 192(49), E1757-E1775.
  62. Wharton, S., Lau, D. C., Vallis, M., Sharma, A. M., Biertho, L., Campbell-Scherer, D., … & Boyling, E. Obesity in adults: a clinical practice guideline. CMAJ. 2020 Aug; 192(31): E875-E891.
  63. Wilding JPH, Batterham RL, Calanna S et al, Once-Weekly Semaglutide in Adults with Overweight and Obesity, N Engl J Med, Feb 2021, DOI: 10.1056/NEJMoa2032183
  64. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology. 2008 Sep; 71(14): 1057-1064
  65. Yang Y, Shields GS, Guo C, Liu Y. Executive function performance in obesity and overweight individuals: A meta-analysis and review. Neurosci Biobehav Rev. 2018 Jan; 84: 225-244

Abonnez-vous à l'infolettre